Hypoxia and cell cycle regulation of the von Hippel–Lindau tumor suppressor (original) (raw)

• Baker DJ, Dawlaty MM, Galardy P, van Deursen JM . (2007). Mitotic regulation of the anaphase-promoting complex. Cell Mol Life Sci 64: 589–600.
  Article CAS PubMed Google Scholar
• Beroud C, Collod-Beroud G, Boileau C, Soussi T, Junien C . (2000). UMD (universal mutation database): a generic software to build and analyze locus-specific databases. Hum Mutat 15: 86–94.
  Article CAS PubMed Google Scholar
• Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A et al. (2006). Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 3: e47.
  Article PubMed PubMed Central Google Scholar
• de Paulsen N, Brychzy A, Fournier MC, Klausner RD, Gnarra JR, Pause A et al. (2001). Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc Natl Acad Sci USA 98: 1387–1392.
  CAS PubMed PubMed Central Google Scholar
• Deshaies RJ, Joazeiro CA . (2009). RING domain E3 ubiquitin ligases. Annu Rev Biochem 78: 399–434.
  Article CAS PubMed Google Scholar
• Fähling M . (2009). Cellular oxygen sensing, signalling and how to survive translational arrest in hypoxia. Acta Physiologica 195: 205–230.
  Article PubMed Google Scholar
• Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV . (2001). Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 276: 7919–7926.
  Article CAS PubMed Google Scholar
• Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC . (2007). HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11: 335–347.
  Article CAS PubMed PubMed Central Google Scholar
• Hackenbeck T, Knaup KX, Schietke R, Schödel J, Willam C, Wu X et al. (2009). HIF-1 or HIF-2 induction is sufficient to achieve cell cycle arrest in NIH3T3 mouse fibroblasts independent from hypoxia. Cell Cycle 8: 1386–1395.
  Article CAS PubMed Google Scholar
• Harper JV . (2005). Synchronization of cell populations in G1/S and G2/M phases of the cell cycle. Methods Mol Biol 296: 157–166.
  CAS PubMed Google Scholar
• Hergovich A, Lisztwan J, Barry R, Ballschmieter P, Krek W . (2003). Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol 5: 64–70.
  Article CAS PubMed Google Scholar
• Iliopoulos O, Kibel A, Gray S, Kaelin WG . (1995). Tumor suppression by the human von Hippel-Lindau gene product. Nat Med 1: 822–826.
  Article CAS PubMed Google Scholar
• Iliopoulos O, Ohh M, Kaelin Jr WG . (1998). pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc Natl Acad Sci USA 95: 11661–11666.
  Article CAS PubMed PubMed Central Google Scholar
• Jackson PK . (2004). Linking tumor suppression, DNA damage and the anaphase-promoting complex. Trends Cell Biol 14: 331–334.
  Article CAS PubMed Google Scholar
• Jung CR, Hwang KS, Yoo J, Cho WK, Kim JM, Kim WH et al. (2006). E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat Med 12: 809–816.
  Article CAS PubMed Google Scholar
• Kaelin WG . (2005). Proline hydroxylation and gene expression. Annu Rev Biochem 74: 115–128.
  Article CAS PubMed Google Scholar
• Kaelin WG . (2007a). Von Hippel-Lindau disease. Annu Rev Pathol 2: 145–173.
  Article CAS PubMed Google Scholar
• Kaelin Jr WG . (2007b). The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma. Clin Cancer Res 13: 680s–684s.
  Article CAS PubMed Google Scholar
• Kaelin Jr WG . (2008). The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 8: 865–873.
  Article CAS PubMed Google Scholar
• Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE . (2004). HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J 23: 1949–1956.
  Article CAS PubMed PubMed Central Google Scholar
• Lendahl U, Lee KL, Yang H, Poellinger L . (2009). Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet 10: 821–832.
  Article CAS PubMed Google Scholar
• Listovsky T, Oren YS, Yudkovsky Y, Mahbubani HM, Weiss AM, Lebendiker M et al. (2004). Mammalian Cdh1/Fzr mediates its own degradation. EMBO J 23: 1619–1626.
  Article CAS PubMed PubMed Central Google Scholar
• Liu L, Simon MC . (2004). Regulation of transcription and translation by hypoxia. Cancer Biol Ther 3: 492–497.
  Article CAS PubMed Google Scholar
• Liu W, Li W, Fujita T, Yang Q, Wan Y . (2008). Proteolysis of CDH1 enhances susceptibility to UV radiation-induced apoptosis. Carcinogenesis 29: 263–272.
  Article CAS PubMed Google Scholar
• Liu W, Wu G, Li W, Lobur D, Wan Y . (2007). Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition. Mol Cell Biol 27: 2967–2979.
  Article CAS PubMed PubMed Central Google Scholar
• Musacchio A, Salmon ED . (2007). The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8: 379–393.
  Article CAS PubMed Google Scholar
• Pause A, Lee S, Lonergan KM, Klausner RD . (1998). The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc Natl Acad Sci USA 95: 993–998.
  Article CAS PubMed PubMed Central Google Scholar
• Pfleger CM, Lee E, Kirschner MW . (2001). Substrate recognition by the Cdc20 and Cdh1 components of the anaphase-promoting complex. Genes Dev 15: 2396–2407.
  Article CAS PubMed PubMed Central Google Scholar
• Schmaltz C, Hardenbergh PH, Wells A, Fisher DE . (1998). Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol 18: 2845–2854.
  Article CAS PubMed PubMed Central Google Scholar
• Schoenfeld A, Davidowitz EJ, Burk RD . (1998). A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc Natl Acad Sci USA 95: 8817–8822.
  Article CAS PubMed PubMed Central Google Scholar
• Semenza GL . (2009). Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood 114: 2015–2019.
  Article CAS PubMed Google Scholar
• Stebbins CE, Kaelin Jr WG, Pavletich NP . (1999). Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284: 455–461.
  Article CAS PubMed Google Scholar
• Stickle NH, Cheng LS, Watson IR, Alon N, Malkin D, Irwin MS et al. (2005). Expression of p53 in renal carcinoma cells is independent of pVHL. Mut Res 578: 23–32.
  Article CAS Google Scholar
• Sudo T, Ota Y, Kotani S, Nakao M, Takami Y, Takeda S et al. (2001). Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells. EMBO J 20: 6499–6508.
  Article CAS PubMed PubMed Central Google Scholar
• Thoma CR, Frew IJ, Hoerner CR, Montani M, Moch H, Krek W . (2007). pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat Cell Biol 9: 588–595.
  Article CAS PubMed Google Scholar
• Thoma CR, Toso A, Gutbrodt KL, Reggi SP, Frew IJ, Schraml P et al. (2009). VHL loss causes spindle misorientation and chromosome instability. Nat Cell Biol 11: 994–1001.
  Article CAS PubMed Google Scholar
• van Leuken R, Clijsters L, Wolthuis R . (2008). To cell cycle, swing the APC/C. Biochimica et Biophysica Acta 1786: 49–59.
  CAS PubMed Google Scholar
• Wan Y, Liu X, Kirschner MW . (2001). The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction. Mol Cell 8: 1027–1039.
  Article CAS PubMed Google Scholar
• Warnecke C, Weidemann A, Volke M, Schietke R, Wu X, Knaup KX et al. (2008). The specific contribution of hypoxia-inducible factor-2alpha to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors. Exp Cell Res 314: 2016–2027.
  Article CAS PubMed Google Scholar
• Wasch R, Robbins JA, Cross FR . (2010). The emerging role of APC/C(Cdh1) in controlling differentiation, genomic stability and tumor suppression. Oncogene 29: 1–10.
  Article CAS PubMed Google Scholar
• Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin Jr WG . (2004). Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428: 194–198.
  Article CAS PubMed Google Scholar
• Wykoff CC, Sotiriou C, Cockman ME, Ratcliffe PJ, Maxwell P, Liu E et al. (2004). Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene. Br J Cancer 90: 1235–1243.
  Article CAS PubMed PubMed Central Google Scholar
• Young AP, Schlisio S, Minamishima YA, Zhang Q, Li L, Grisanzio C et al. (2008). VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nat Cell Biol 10: 361–369.
  Article CAS PubMed Google Scholar